{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:16:12Z","timestamp":1788844572862,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.mam.2023.101195","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T13:02:02Z","timestamp":1689426122000},"page":"101195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7556-4658","authenticated-orcid":false,"given":"Anne","family":"Hedengran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-0734","authenticated-orcid":false,"given":"Miriam","family":"Kolko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib1","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1755-3768.2012.02565.x","article-title":"Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study","volume":"91","author":"Aihara","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/JEP.S259297","article-title":"Investigational rho kinase inhibitors for the treatment of glaucoma","volume":"13","author":"Al-Humimat","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.mam.2023.101195_bib3","first-page":"1806","article-title":"Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells","volume":"17","author":"Ammar","year":"2011","journal-title":"Mol. Vis."},{"issue":"10","key":"10.1016\/j.mam.2023.101195_bib4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/bjophthalmol-2011-300012","article-title":"Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines","volume":"95","author":"Ammar","year":"2011","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","article-title":"Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells","volume":"27","author":"Ammar","year":"2010","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12325-011-0029-x","article-title":"Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells","volume":"28","author":"Ammar","year":"2011","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/bjo.2005.078865","article-title":"Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome","volume":"90","author":"Aragona","year":"2006","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.exer.2011.04.002","article-title":"Update on the role of alpha-agonists in glaucoma management","volume":"93","author":"Arthur","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101195_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106315","article-title":"Trends in development and quality assessment of pharmaceutical formulations - F2\u03b1 analogues in the glaucoma treatment","volume":"180","author":"Asendrych-Wicik","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.mam.2023.101195_bib10","series-title":"StatPearls [Internet]. Treasure Island (FL)","article-title":"Carbonic anhydrase inhibitors","author":"Aslam","year":"2022"},{"key":"10.1016\/j.mam.2023.101195_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S13406","article-title":"Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines","volume":"4","author":"Ayaki","year":"2010","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4265\/bio.17.115","article-title":"Comparative study of in vitro ocular surface cytotoxicity of a fixed combination of 0.5% timolol\/1% dorzolamide eyedrop and its components with 0.005% benzalkonium chloride","volume":"17","author":"Ayaki","year":"2012","journal-title":"Biocontrol Sci."},{"key":"10.1016\/j.mam.2023.101195_bib13","article-title":"The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study","author":"Aydin Kurna","year":"2014","journal-title":"J. Ophthalmol. 2014"},{"issue":"10","key":"10.1016\/j.mam.2023.101195_bib14","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1167\/iovs.14-14548","article-title":"The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye","volume":"55","author":"Barabino","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101195_bib15","series-title":"StatPearls [Internet]","article-title":"Timolol","author":"Barnes","year":"2022"},{"key":"10.1016\/j.mam.2023.101195_bib16","first-page":"40","article-title":"In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis)","volume":"110","author":"Baudouin","year":"2012","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.mam.2023.101195_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tiv.2017.02.006","article-title":"Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma","volume":"41","author":"Bouchemi","year":"2017","journal-title":"Toxicol. Vitro"},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024129","article-title":"Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study","volume":"9","author":"Bourne","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050180","article-title":"A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits","volume":"7","author":"Brignole-Baudouin","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/02713683.2011.578781","article-title":"Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells","volume":"36","author":"Brignole-Baudouin","year":"2011","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jop.2010.0111","article-title":"In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost\/timolol fixed combination and latanoprost\/timolol fixed combination","volume":"27","author":"Brignole-Baudouin","year":"2011","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2165\/00002512-199202030-00005","article-title":"Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects","volume":"2","author":"Brooks","year":"1992","journal-title":"Drugs Aging"},{"issue":"Pt 1","key":"10.1016\/j.mam.2023.101195_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20031705","article-title":"Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway","volume":"381","author":"Budd","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.mam.2023.101195_bib24","series-title":"StatPearls [Internet]","article-title":"Muscarinic agonists","author":"Bui","year":"2022"},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ceo.12390","article-title":"Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost","volume":"43","author":"Chang","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"12","key":"10.1016\/j.mam.2023.101195_bib26","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/ICO.0b013e3182a8196f","article-title":"Changes in rabbit corneal innervation induced by the topical application of benzalkonium chloride","volume":"32","author":"Chen","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12325-013-0014-7","article-title":"Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension","volume":"30","author":"Crichton","year":"2013","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib28","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1167\/iovs.16-20903","article-title":"The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells","volume":"58","author":"Datta","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib29","first-page":"642","article-title":"Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/mi.2012.43","article-title":"CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation","volume":"5","author":"Denoyer","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000134928","article-title":"Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug","volume":"40","author":"Denoyer","year":"2008","journal-title":"Ophthalmic Res."},{"issue":"12","key":"10.1016\/j.mam.2023.101195_bib32","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1007\/s00216-013-6811-7","article-title":"Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry","volume":"405","author":"Desbenoit","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul. Surf."},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/jop.2008.0140","article-title":"Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101195_bib35","first-page":"1","article-title":"European glaucoma society terminology and guidelines for glaucoma, 5th edition","volume":"105","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib36","series-title":"Generic and Hybrid Medicines","year":"2007"},{"key":"10.1016\/j.mam.2023.101195_bib37","series-title":"Questions and Answers on the Use of Phosphates in Eye Drops","year":"2012"},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cxo.12853","article-title":"Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension","volume":"102","author":"Fingeret","year":"2019","journal-title":"Clin. Exp. Optom."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12325-015-0205-5","article-title":"A 1-year randomized study of the clinical and confocal effects of tafluprost and latanoprost in newly diagnosed glaucoma patients","volume":"32","author":"Fogagnolo","year":"2015","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/17469899.4.1.59","article-title":"Preservatives in topical ophthalmic medications: historical and clinical perspectives","volume":"4","author":"Freeman","year":"2009","journal-title":"Expet Rev. Ophthalmol."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib41","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/aos.12261","article-title":"In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma","volume":"92","author":"Frezzotti","year":"2014","journal-title":"Acta Ophthalmol."},{"issue":"10","key":"10.1016\/j.mam.2023.101195_bib42","first-page":"4025","article-title":"Analysis of the effects of preservative-free tafluprost on the tear proteome","volume":"8","author":"Funke","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"1\u20132","key":"10.1016\/j.mam.2023.101195_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(00)00540-8","article-title":"Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants","volume":"207","author":"Furrer","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mam.2023.101195_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol. J."},{"issue":"7","key":"10.1016\/j.mam.2023.101195_bib45","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1167\/iovs.04-1331","article-title":"In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells","volume":"46","author":"Guenoun","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.mam.2023.101195_bib46","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00417-003-0777-7","article-title":"In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells","volume":"241","author":"Hamard","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000517845","article-title":"Benzalkonium chloride-preserved anti-glaucomatous eye drops and their effect on human conjunctival goblet cells in vitro","volume":"6","author":"Hedengran","year":"2021","journal-title":"Biomed. Hub"},{"issue":"7","key":"10.1016\/j.mam.2023.101195_bib48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/aos.15163","article-title":"Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: effect on cultured human conjunctival goblet cells and their physicochemical properties","volume":"100","author":"Hedengran","year":"2022","journal-title":"Acta Ophthalmol."},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib49","first-page":"1512","article-title":"Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis","volume":"104","author":"Hedengran","year":"2020","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40265-017-0843-9","article-title":"Preservative-free prostaglandin analogs and prostaglandin\/timolol fixed combinations in the treatment of glaucoma: efficacy, safety and potential advantages","volume":"78","author":"Holl\u00f3","year":"2018","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.mam.2023.101195_bib51","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/IJG.0b013e31824d8d7c","article-title":"Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs","volume":"22","author":"Inoue","year":"2013","journal-title":"J. Glaucoma"},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib52","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1038\/s41598-021-88562-4","article-title":"Prostaglandin F2\u03b1 agonists induced enhancement in collagen1 expression is involved in the pathogenesis of the deepening of upper eyelid sulcus","volume":"11","author":"Itoh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101195_bib53","series-title":"58 - Ocular Surface Disease and the Role of Preservatives in Glaucoma Medications","first-page":"593","author":"Ittoop","year":"2015"},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yrtph.2013.03.014","article-title":"Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines","volume":"66","author":"Iwasawa","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.mam.2023.101195_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2014.11.006","article-title":"Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork","volume":"772","author":"Izzotti","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mam.2023.101195_bib56","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.2147\/OPTH.S382497","article-title":"Tolerability in glaucoma patients switched from preserved to preservative-free prostaglandin-timolol combination: a prospective real-life study","volume":"16","author":"Jandrokovi\u0107","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.exer.2016.01.017","article-title":"Unconventional aqueous humor outflow: a review","volume":"158","author":"Johnson","year":"2017","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib58","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4103\/ijo.IJO_1971_21","article-title":"Effect of prostaglandin analogues on central corneal thickness in patients with glaucoma: a systematic review and meta-analysis with trial sequential analysis","volume":"70","author":"Kadri","year":"2022","journal-title":"Indian J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.mam.2023.101195_bib59","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12325-008-0078-y","article-title":"Quantitative analysis of conjunctival goblet cells after chronic application of topical drops","volume":"25","author":"Kahook","year":"2008","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICO.0b013e31815cf651","article-title":"Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears","volume":"27","author":"Kahook","year":"2008","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/jop.2014.0104","article-title":"Comparison of the toxicity profile of benzalkonium chloride-preserved tafluprost and SofZia-preserved travoprost applied to the ocular surface","volume":"31","author":"Kanamoto","year":"2015","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101195_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/ceo.14224","article-title":"ROCK inhibitors in ophthalmology: a critical review of the existing clinical evidence","author":"Karri","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10792-017-0792-z","article-title":"Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients","volume":"39","author":"Kestelyn","year":"2019","journal-title":"Int. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jop.2014.0146","article-title":"Effect of AR-13324 on episcleral venous pressure in Dutch belted rabbits","volume":"31","author":"Kiel","year":"2015","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10384-011-0008-4","article-title":"Effects of benzalkonium chloride on the ocular surface of the rabbit","volume":"55","author":"Kim","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.mam.2023.101195_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132048","article-title":"The prevalence and incidence of glaucoma in Denmark in a fifteen year period: a nationwide study","volume":"10","author":"Kolko","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib67","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/aos.13355","article-title":"The physical properties of generic latanoprost ophthalmic solutions are not identical","volume":"95","author":"Kolko","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/IJG.0b013e318181284f","article-title":"Mitochondrial dysfunction and glaucoma","volume":"18","author":"Kong","year":"2009","journal-title":"J. Glaucoma"},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib69","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/14740338.2021.1873947","article-title":"The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability","volume":"20","author":"Konstas","year":"2021","journal-title":"Expet Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib70","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12325-014-0125-9","article-title":"24-hour efficacy of travoprost\/timolol BAK-free versus latanoprost\/timolol fixed combinations in patients insufficiently controlled with latanoprost","volume":"31","author":"Konstas","year":"2014","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.22336\/rjo.2019.38","article-title":"Ocular surface disease with BAK preserved travoprost and polyquaternium 1(polyquad) preserved travoprost","volume":"63","author":"Kumar","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jop.2006.22.267","article-title":"Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study","volume":"22","author":"Labb\u00e9","year":"2006","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101195_bib73","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2147\/OPTH.S118689","article-title":"Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution","volume":"11","author":"Lee","year":"2017","journal-title":"Clin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib74","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1167\/iovs.12-9596","article-title":"Impaired complex-I-linked respiration and ATP synthesis in primary open-angle glaucoma patient lymphoblasts","volume":"53","author":"Lee","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J. Glaucoma"},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033913","article-title":"Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12325-011-0003-7","article-title":"Polyquad-preserved travoprost\/timolol, benzalkonium chloride (BAK)-preserved travoprost\/timolol, and latanoprost\/timolol in fixed combinations: a rabbit ocular surface study","volume":"28","author":"Liang","year":"2011","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000335984","article-title":"Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions","volume":"48","author":"Liang","year":"2012","journal-title":"Ophthalmic Res."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib79","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2010.189449","article-title":"Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system","volume":"95","author":"Liang","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib80","first-page":"257","article-title":"A mouse dry eye model induced by topical administration of benzalkonium chloride","volume":"17","author":"Lin","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mam.2023.101195_bib81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biochi.2020.07.015","article-title":"Lipidomic analysis of human corneal epithelial cells exposed to ocular irritants highlights the role of phospholipid and sphingolipid metabolisms in detergent toxicity mechanisms","volume":"178","author":"Magny","year":"2020","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.mam.2023.101195_bib82","article-title":"Lipidomic analysis of epithelial corneal cells following hyperosmolarity and benzalkonium chloride exposure: new insights in dry eye disease","volume":"1865","author":"Magny","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-0420.1996.tb00086.x","article-title":"Viscous carbomer eye drops in patients with dry eyes. Efficacy and safety. A randomized, open, cross-over, multicentre study","volume":"74","author":"Marner","year":"1996","journal-title":"Acta Ophthalmol. Scand."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib84","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12253-014-9755-0","article-title":"Confocal microscopy of epithelial and langerhans cells of the cornea in patients using travoprost drops containing two different preservatives","volume":"20","author":"Marsovszky","year":"2014","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib85","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2008.10.019","article-title":"An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology","volume":"147","author":"Martone","year":"2009","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib86","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib87","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.tiv.2011.03.007","article-title":"Spectrofluorometry assays for oxidative stress and apoptosis, with cell viability on the same microplates: a multiparametric analysis and quality control","volume":"25","author":"Mehanna","year":"2011","journal-title":"Toxicol. Vitro"},{"issue":"9","key":"10.1016\/j.mam.2023.101195_bib88","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/156802607780636735","article-title":"The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents","volume":"7","author":"Mincione","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1120672118785280","article-title":"The RELIEF study: tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension","volume":"29","author":"Misiuk-Hojlo","year":"2019","journal-title":"Eur. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.mam.2023.101195_bib90","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/ceo.13814","article-title":"Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: a 2-year randomized evaluation study","volume":"48","author":"Mohammed","year":"2020","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib91","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4103\/ijo.IJO_2239_21","article-title":"Newer advances in medical management of glaucoma","volume":"70","author":"Mohan","year":"2022","journal-title":"Indian J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.mam.2023.101195_bib92","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.19082\/2954","article-title":"Adherence to treatment in patients with open-angle glaucoma and its related factors","volume":"8","author":"Movahedinejad","year":"2016","journal-title":"Electron. Physician"},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.11.5.28","article-title":"Dynamic contrast microscopic optical coherence tomography as a novel method for assessing corneal epithelium during exposure to benzalkonium chloride","volume":"11","author":"Musial","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib94","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1007\/s10792-021-01947-2","article-title":"Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension","volume":"41","author":"Muz","year":"2021","journal-title":"Int. Ophthalmol."},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib95","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/14740338.2016.1225718","article-title":"Cardiac safety of ophthalmic timolol","volume":"15","author":"M\u00e4enp\u00e4\u00e4","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53390-0","article-title":"D-sorbitol can keep the viscosity of dispersive ophthalmic viscosurgical device at room temperature for long term","volume":"9","author":"Nogami","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/14656566.2018.1544241","article-title":"Brimonidine tartrate for the treatment of glaucoma","volume":"20","author":"Oh","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib99","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2131\/jts.38.531","article-title":"Local toxicity of benzalkonium chloride in ophthalmic solutions following repeated applications","volume":"38","author":"Okahara","year":"2013","journal-title":"J. Toxicol. Sci."},{"issue":"13","key":"10.1016\/j.mam.2023.101195_bib100","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1167\/iovs.12-10766","article-title":"In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation","volume":"53","author":"Pauly","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713683.2011.626909","article-title":"The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo","volume":"37","author":"Pellinen","year":"2012","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib102","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma","volume":"156","author":"Peters","year":"2013","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.mam.2023.101195_bib103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/aos.12203","article-title":"Factors associated with lifetime risk of open-angle glaucoma blindness","volume":"92","author":"Peters","year":"2014","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib104","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/09273948.2017.1372485","article-title":"The effect of latanaprost on intraocular inflammation and macular edema","volume":"27","author":"Razeghinejad","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ceo.14040","article-title":"Primary glaucomas in adults: epidemiology and public health-A review","volume":"50","author":"Reis","year":"2022","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8956504","article-title":"Mitochondrial dysfunctions may Be one of the major causative factors underlying detrimental effects of benzalkonium chloride","volume":"2020","author":"Rogov","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10792-021-02002-w","article-title":"Status of Rho kinase inhibitors in glaucoma therapeutics-an overview","volume":"42","author":"Saha","year":"2022","journal-title":"Int. Ophthalmol."},{"issue":"8","key":"10.1016\/j.mam.2023.101195_bib108","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.burns.2019.04.022","article-title":"Irrigation with phosphate-buffered saline causes corneal calcification during treatment of ocular burns","volume":"45","author":"Schrage","year":"2019","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.mam.2023.101195_bib109","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/ICO.0000000000001199","article-title":"Implications for ophthalmic formulations: ocular buffers show varied cytotoxic impact on human corneal-limbal and human conjunctival epithelial cells","volume":"36","author":"Schuerer","year":"2017","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/15569527.2020.1787435","article-title":"Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film","volume":"39","author":"Sedlak","year":"2020","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3341\/kjo.2021.0010","article-title":"Efficacy and safety of preservative-free latanoprost eyedrops compared with preserved prostaglandin analogues in patients with open-angle glaucoma","volume":"35","author":"Seong","year":"2021","journal-title":"Kor. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib112","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of Netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.mam.2023.101195_bib113","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/jop.2013.0248","article-title":"Effects of polyquaternium- and benzalkonium-chloride-preserved travoprost on ocular surfaces: an impression cytology study","volume":"30","author":"Sezgin Ak\u00e7ay","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib114","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2217\/17410541.5.4.377","article-title":"Pharmacogenetics of ophthalmic topical beta-blockers","volume":"5","author":"Sidjanin","year":"2008","journal-title":"Per. Med."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.mam.2023.101195_bib116","first-page":"175","article-title":"Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells","volume":"2","author":"Smedowski","year":"2014","journal-title":"J. Biochem. Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.mam.2023.101195_bib117","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/OPX.0000000000001782","article-title":"Meibomian gland changes in open-angle glaucoma users treated with topical medication","volume":"98","author":"Soriano","year":"2021","journal-title":"Optom. Vis. Sci."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib118","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/j.1755-3768.2011.02338.x","article-title":"Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial","volume":"90","author":"Stevens","year":"2012","journal-title":"Acta Ophthalmol."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101195_bib119","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/S0039-6257(02)00292-8","article-title":"Mechanism and clinical significance of prostaglandin-induced iris pigmentation","volume":"47","author":"Stjernschantz","year":"2002","journal-title":"Surv. Ophthalmol."},{"issue":"10","key":"10.1016\/j.mam.2023.101195_bib120","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bjophthalmol-2021-319530","article-title":"Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?","volume":"106","author":"Stoner","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib121","series-title":"StatPearls [Internet]. Treasure Island (FL)","article-title":"Physiology, aqueous humor circulation","author":"Sunderland","year":"2023"},{"key":"10.1016\/j.mam.2023.101195_bib122","series-title":"StatPearls [Internet]","article-title":"Betaxolol","author":"Tajran","year":"2022"},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib123","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101195_bib124","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ajo.2022.05.007","article-title":"Adverse effects and safety in glaucoma patients: agreement on clinical trial outcomes for reports on eye drops (ASGARD)-A delphi consensus statement","volume":"241","author":"Thein","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib125","article-title":"Changes in ocular surface characteristics after switching from benzalkonium chloride-preserved latanoprost to preservative-free tafluprost or benzalkonium chloride-preserved tafluprost","author":"Tokuda","year":"2017","journal-title":"J. Ophthalmol. 2017"},{"issue":"2","key":"10.1016\/j.mam.2023.101195_bib126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1542-0124(12)70157-X","article-title":"Assessment of tear film dynamics: quantification approach","volume":"3","author":"Tomlinson","year":"2005","journal-title":"Ocul. Surf."},{"issue":"8","key":"10.1016\/j.mam.2023.101195_bib127","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/02713683.2019.1597127","article-title":"Effects of anti-glaucoma prostaglandin ophthalmic solutions on cultured human corneal epithelial cells","volume":"44","author":"Tong","year":"2019","journal-title":"Curr. Eye Res."},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib128","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bjo.2010.193987","article-title":"Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature","volume":"95","author":"Tressler","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101195_bib129","series-title":"Latanoprost (Xalatan): Increased Reporting of Eye Irritation since Reformulation","year":"2015"},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","article-title":"Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib131","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1167\/iovs.15-17455","article-title":"The ocular surface in medically controlled glaucoma: an in vivo confocal study","volume":"57","author":"Villani","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101195_bib132","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2019.10.014","article-title":"Benzalkonium chloride-induced direct and indirect toxicity on corneal epithelial and trigeminal neuronal cells: proinflammatory and apoptotic responses in vitro","volume":"319","author":"Vitoux","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mam.2023.101195_bib133","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","volume":"13","author":"Walsh","year":"2019","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib134","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/IJG.0b013e3182952213","article-title":"Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes","volume":"24","author":"Wang","year":"2015","journal-title":"J. Glaucoma"},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000448117","article-title":"Hyperosmolarity and benzalkonium chloride differently stimulate inflammatory markers in conjunctiva-derived epithelial cells in vitro","volume":"58","author":"Warcoin","year":"2017","journal-title":"Ophthalmic Res."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib136","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jop.2009.0134","article-title":"Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension","volume":"26","author":"Whitson","year":"2010","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2\u20133","key":"10.1016\/j.mam.2023.101195_bib137","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/jop.2013.0179","article-title":"Effects of prostaglandin analogues on aqueous humor outflow pathways","volume":"30","author":"Winkler","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.mam.2023.101195_bib138","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00417-021-05379-7","article-title":"Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials","volume":"260","author":"Wu","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.mam.2023.101195_bib139","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/jop.2021.0071","article-title":"Ocular surface disease in glaucoma patients randomized to benzalkonium chloride-containing latanoprost and preservative-free bimatoprost","volume":"37","author":"Wu","year":"2021","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.mam.2023.101195_bib140","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1167\/iovs.13-13842","article-title":"The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma","volume":"55","author":"Yamamoto","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101195_bib141","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jenvman.2013.04.056","article-title":"Adsorption of the disinfectant benzalkonium chloride on montmorillonite. Synergistic effect in mixture of molecules with different chain lengths","volume":"128","author":"Zanini","year":"2013","journal-title":"J. Environ. Manag."},{"issue":"1","key":"10.1016\/j.mam.2023.101195_bib142","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jtos.2019.11.006","article-title":"Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease","volume":"18","author":"Zhang","year":"2020","journal-title":"Ocul. Surf."},{"issue":"8","key":"10.1016\/j.mam.2023.101195_bib143","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3109\/02713683.2010.489181","article-title":"Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers","volume":"35","author":"Zhivov","year":"2010","journal-title":"Curr. Eye Res."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:20:48Z","timestamp":1758824448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299723000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":143,"alternative-id":["S0098299723000353"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2023.101195","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2023.101195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101195"}}